| 000 | 01777 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517014433.0 | ||
| 264 | 0 | _c20150623 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1096-8652 | ||
| 024 | 7 |
_a10.1002/ajh.23965 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmadi, Ashkan | |
| 245 | 0 | 0 |
_aPresence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cMay 2015 |
||
| 300 |
_aE77-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 |
_aAzacitidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDNA Modification Methylases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDecitabine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsocitrate Dehydrogenase _xgenetics |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aFaramand, Rawan | |
| 700 | 1 | _aCarter-Cooper, Brandon | |
| 700 | 1 | _aTolu, Seda | |
| 700 | 1 | _aFord, Laurie A | |
| 700 | 1 | _aLapidus, Rena G | |
| 700 | 1 | _aWetzler, Meir | |
| 700 | 1 | _aWang, Eunice S | |
| 700 | 1 | _aEtemadi, Arash | |
| 700 | 1 | _aGriffiths, Elizabeth A | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 90 _gno. 5 _gp. E77-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.23965 _zAvailable from publisher's website |
| 999 |
_c24593896 _d24593896 |
||